Zynerba Pharmaceuticals, Inc. 4
4 · Zynerba Pharmaceuticals, Inc. · Filed Sep 15, 2015
Insider Transaction Report
Form 4
BARON RICHARD A
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option
2015-09-11−15,957→ 47,872 totalExercise: $3.98Exp: 2025-01-02→ Common Stock (15,957 underlying) - Exercise/Conversion
Common Stock
2015-09-11$3.98/sh+15,957$63,509→ 15,957 total
Footnotes (1)
- [F1]The stock option vested as to 25% of the common stock (15,957 shares) as of the date of the closing of the Issuer's initial public offering, with the balance vesting in twelve equal quarterly installments thereafter.